| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6061899 | Annals of Allergy, Asthma & Immunology | 2014 | 11 Pages |
Abstract
ASHMI treatment was efficacious in a murine model of neutrophil-predominant asthma via modulation of innate chemokines, TH2 responses, nuclear factor-κB, and HDAC2. ASHMI, and/or its constituent GAC1, may be a valuable option for treating neutrophil-predominant asthma.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Kamal D. PhD, David MD, Changda PhD, Nan PhD, Rachel L. MD, Hugh A. MD, Xiu-Min MD, MS,